News
Press Releases and Media
Attralus Appoints James Testa as Vice President of Finance
Attralus Presents Positive New Data at 2021 American Society of Hematology Annual Meeting
Attralus to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
Attralus to Present New Data at 2021 American Society of Hematology Annual Meeting
Attralus Closes $116 Million Series B Financing
Attralus Appoints Jake Bauer to Board of Directors
Attralus Announces Presentation of Clinical Data on AT-01, a Novel Diagnostic for Systemic Amyloidosis, at the 2021 Society of Nuclear Molecular Imaging Meeting
Attralus Announces Presentation of Clinical Data on AT-01, a Novel, Potential First-in-Class Diagnostic for Systemic Amyloidosis at the 2021 American College of Cardiology Annual Meeting
Attralus Appoints Mark Timney as CEO and Expands Leadership Team with New Executives
Attralus Presents Clinical Data from Novel, Potential First-in-Class Diagnostic AT-01 for Systemic Amyloidosis at Virtual ASH 2020
Attralus to Present Clinical Data at Upcoming Virtual ASH 2020
Attralus Presents Preclinical and Clinical Data at 17th International Symposium on Amyloidosis
Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis
prnewswire.com
Aurora Bio, Inc Announces Clinical Data on Lead Program
businesswire.com